Alexa S. Beiser

ORCID: 0000-0001-8551-7778
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Cerebrovascular and Carotid Artery Diseases
  • Alzheimer's disease research and treatments
  • Acute Ischemic Stroke Management
  • Cardiovascular Health and Disease Prevention
  • Genetic Associations and Epidemiology
  • Blood Pressure and Hypertension Studies
  • Nutritional Studies and Diet
  • Advanced Neuroimaging Techniques and Applications
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Folate and B Vitamins Research
  • Functional Brain Connectivity Studies
  • Diet and metabolism studies
  • Sleep and Wakefulness Research
  • Cardiovascular Health and Risk Factors
  • Sleep and related disorders
  • Epigenetics and DNA Methylation
  • Cardiovascular Disease and Adiposity
  • Health, Environment, Cognitive Aging
  • Neurological Disease Mechanisms and Treatments
  • Cerebrovascular and genetic disorders
  • Nutrition and Health in Aging
  • Adipokines, Inflammation, and Metabolic Diseases
  • Advanced MRI Techniques and Applications
  • Genetics and Neurodevelopmental Disorders

Boston University
2016-2025

Framingham Heart Study
2016-2025

National Heart Lung and Blood Institute
2014-2025

The University of Texas Health Science Center at San Antonio
2018-2024

University of Haifa
2024

Monash University
2022-2024

Brigham and Women's Hospital
2015-2023

Institute for Neurodegenerative Disorders
2018-2023

Harbor–UCLA Medical Center
2023

Douglas Mental Health University Institute
2023

In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the precede onset or result from dementia-related nutritional vitamin deficiencies.

10.1056/nejmoa011613 article EN New England Journal of Medicine 2002-02-14

Background— Atrial fibrillation (AF) is the most common cardiac dysrhythmia and a source of considerable morbidity mortality, but lifetime risk for AF has not been estimated. Methods Results— We included all participants in Framingham Heart Study who were free at index ages 40 years older. estimated risks (including atrial flutter) to age 95 years, with death as competing event. followed 3999 men 4726 women from 1968 1999 (176 166 person-years); 936 had development 2621 died without prior...

10.1161/01.cir.0000140263.20897.42 article EN Circulation 2004-08-17
Verneri Anttila Brendan Bulik‐Sullivan Hilary K. Finucane Raymond K. Walters José Brás and 95 more Laramie E. Duncan Valentina Escott‐Price Guido J. Falcone Padhraig Gormley Rainer Malik Nikolaos A. Patsopoulos Stephan Ripke Zhi Wei Dongmei Yu Phil H. Lee Patrick Turley Benjamin Grenier‐Boley Vincent Chouraki Yoichiro Kamatani Claudine Berr Luc Letenneur Didier Hannequin Philippe Amouyel Anne Boland Jean‐François Deleuze Emmanuelle Duron Badri N. Vardarajan Christiane Reitz Alison Goate Matthew J. Huentelman M. Ilyas Kamboh Eric B. Larson Ekaterina Rogaeva Peter St George‐Hyslop Hákon Hákonarson Walter A. Kukull Lindsay A. Farrer Lisa L. Barnes Thomas G. Beach F. Yesim Demirci Elizabeth Head Christine M. Hulette Gregory A. Jicha John S.K. Kauwe Jonathan Kaye James B. Leverenz Allan I. Levey Andrew P. Lieberman V. Shane Pankratz Wayne W. Poon Joseph F. Quinn Andrew J. Saykin Lon S. Schneider Amanda Smith Joshua A. Sonnen Robert A. Stern Vivianna M. Van Deerlin Linda J. Van Eldik Denise Harold Giancarlo Russo David C. Rubinsztein Antony Bayer Magda Tsolaki Petroula Proitsi Nick C. Fox Harald Hampel Michael J. Owen Simon Mead Peter Passmore Kevin Morgan Markus M. Nöthen Jonathan M. Schott Martin N. Rossor Michelle K. Lupton Per Hoffmann Johannes Kornhuber Brian Lawlor Andrew McQuillin Ammar Al‐Chalabi Joshua C. Bis Agustı́n Ruiz Merçé Boada Sudha Seshadri Alexa S. Beiser Kenneth Rice Sven J. van der Lee Philip L. De Jager Daniel H. Geschwind Markus J. Riemenschneider Steffi G. Riedel‐Heller Jerome I. Rotter Gerhard Ransmayr Bradley T. Hyman Carlos Cruchaga Montserrat Alegret Bendik S. Winsvold Priit Palta Kai-How Farh Ester Cuenca-León Nicholas A. Furlotte

Disorders of the brain can exhibit considerable epidemiological comorbidity and often share symptoms, provoking debate about their etiologic overlap. We quantified genetic sharing 25 disorders from genome-wide association studies 265,218 patients 784,643 control participants assessed relationship to 17 phenotypes 1,191,588 individuals. Psychiatric common variant risk, whereas neurological appear more distinct one another psychiatric disorders. also identified significant between a number...

10.1126/science.aap8757 article EN Science 2018-06-21

Background— Congestive heart failure (CHF) is an increasing public health problem. Methods and Results— Among Framingham Heart Study subjects who were free of CHF at baseline, we determined the lifetime risk for developing overt selected index ages. We followed 3757 men 4472 women from 1971 to 1996 124 262 person-years; 583 developed 2002 died without prior CHF. At age 40 years, was 21.0% (95% CI 18.7% 23.2%) 20.3% 18.2% 22.5%) women. Remaining did not change with advancing because rapidly...

10.1161/01.cir.0000039105.49749.6f article EN Circulation 2002-12-10
Céline Bellenguez Fahri Küçükali Iris E. Jansen Luca Kleineidam Sonia Moreno‐Grau and 95 more Najaf Amin Adam C. Naj Rafael Campos‐Martin Benjamin Grenier‐Boley Víctor Andrade Peter Holmans Anne Boland Vincent Damotte Sven J. van der Lee Marcos R. Costa Teemu Kuulasmaa Qiong Yang Itziar de Rojas Joshua C. Bis Amber Yaqub Ivana Nedeljković Julien Chapuis Shahzad Ahmad Vilmantas Giedraitis Dag Aarsland Pablo García‐González Carla Abdelnour Emilio Alarcón‐Martín Daniel Alcolea Montserrat Alegret Ignacio Álvarez Victoria Álvarez Nicola J. Armstrong Anthoula Tsolaki Carmen Antúnez Ildebrando Appollonio Marina Arcaro Silvana Archetti Alfonso Arias Pastor Beatrice Arosio Lavinia Athanasiu Henri Bailly Nerisa Banaj Miquel Baquero Sandra Barral Alexa S. Beiser Ana Belén Pastor Jennifer E. Below Penelope Benchek Luisa Benussi Claudine Berr Céline Besse Valentina Bessi Giuliano Binetti Alessandra Bizarro Rafael Blesa Merçé Boada Eric Boerwinkle Barbara Borroni Silvia Boschi Paola Bossù Geir Bråthen Jan Bressler Catherine Bresner Henry Brodaty Keeley J. Brookes Luis I. Brusco Dolores Buiza‐Rueda Katharina Bürger Vanessa Burholt William S. Bush Miguel Calero Laura B. Cantwell Geneviève Chêne Jaeyoon Chung Michael L. Cuccaro Ángel Carracedo Roberta Cecchetti Laura Cervera‐Carles Camille Charbonnier Hung‐Hsin Chen Caterina Chillotti Simona Ciccone Jurgen A.H.R. Claassen Christopher Clark Elisa Conti Anaïs Corma‐Gómez Emanuele Maria Costantini Carlo Custodero Delphine Daian Carolina Dalmasso Antonio Daniele Efthimios Dardiotis Jean‐François Dartigues Peter Paul De Deyn Kátia de Paiva Lopes Lot D. de Witte Stéphanie Debette Jürgen Deckert Teodoro del Ser

Abstract Characterization of the genetic landscape Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for better understanding associated pathophysiological processes. We performed two-stage genome-wide association study totaling 111,326 clinically diagnosed/‘proxy’ AD cases 677,663 controls. found 75 risk loci, which 42 were new at time analysis. Pathway enrichment analyses confirmed involvement amyloid/tau pathways highlighted microglia implication. Gene...

10.1038/s41588-022-01024-z article EN cc-by Nature Genetics 2022-04-01

ContextThe long-term risk for developing hypertension is best described by the lifetime statistic. The and trends in this over time are unknown.ObjectivesTo estimate residual older US adults to evaluate temporal risk.Design, Setting, ParticipantsCommunity-based prospective cohort study of 1298 participants from Framingham Heart Study who were aged 55 65 years free at baseline (1976-1998).Main Outcome MeasuresResidual (lifetime cumulative incidence not adjusted competing causes mortality)...

10.1001/jama.287.8.1003 article EN JAMA 2002-02-27

We compared the efficacy of intravenous gamma globulin plus aspirin with that alone in reducing frequency coronary-artery abnormalities children acute Kawasaki syndrome a multicenter, randomized trial. Children randomly assigned to group received globulin, 400 mg per kilogram body weight day, for four consecutive days; both treatment groups aspirin, 100 through 14th day illness, then 3 5 day. Two-dimensional echocardiograms were interpreted blindly and independently by two or more readers....

10.1056/nejm198608073150601 article EN New England Journal of Medicine 1986-08-07

Background and Purpose Stroke occurring with atrial fibrillation (AF) is more likely to be fatal or severe than non-AF stroke based on clinical series, but data from prospective epidemiological studies are sparse inconsistent. Methods Over 40-year follow-up of the original 5070 Framingham cohort, 501 initial ischemic strokes, including 103 AF, were analyzed. severity was rated as none, mild, moderate, severe, fatal. Since 1981, functional status indicated by Barthel index has been evaluated...

10.1161/01.str.27.10.1760 article EN Stroke 1996-10-01

Lifetime risk for atherosclerotic cardiovascular disease (CVD) has not previously been estimated, and the effect of factor burden on lifetime is unknown.We included all Framingham Heart Study participants who were free CVD (myocardial infarction, coronary insufficiency, angina, stroke, claudication) at 50 years age. risks to 95 age estimated men women, with death as a competing event. We followed up 3564 4362 women 111,777 person-years; 1757 had events 1641 died CVD. At age, 51.7% (95% CI,...

10.1161/circulationaha.105.548206 article EN Circulation 2006-02-07

Treatment of acute Kawasaki syndrome with a four-day course intravenous gamma globulin, together aspirin, has been demonstrated to be safe and effective in preventing coronary-artery lesions reducing systemic inflammation. We hypothesized that therapy single, very high dose globulin would at least as the standard regimen.

10.1056/nejm199106063242305 article EN New England Journal of Medicine 1991-06-06

The prevalence of dementia is expected to soar as the average life expectancy increases, but recent estimates suggest that age-specific incidence declining in high-income countries. Temporal trends are best derived through continuous monitoring a population over long period with use consistent diagnostic criteria. We describe temporal three decades among participants Framingham Heart Study.

10.1056/nejmoa1504327 article EN New England Journal of Medicine 2016-02-11
Rebecca Sims Sven J. van der Lee Adam C. Naj Céline Bellenguez Nandini Badarinarayan and 95 more Jóhanna Jakobsdóttir Brian W. Kunkle Anne Boland Rachel Raybould Joshua C. Bis Eden R. Martin Benjamin Grenier‐Boley Stefanie Heilmann‐Heimbach Vincent Chouraki Amanda Kuzma Kristel Sleegers Maria Vronskaya Agustı́n Ruiz Robert Graham Robert Olaso Per Hoffmann Megan L. Grove Badri N. Vardarajan Mikko Hiltunen Markus M. Nöthen Charles C. White Kara L. Hamilton‐Nelson Jacques Epelbaum Wolfgang Maier Seung-Hoan Choi Gary W. Beecham Cécile Dulary Stefan Herms Albert V. Smith Cory C. Funk Céline Derbois Andreas J. Forstner Shahzad Ahmad Hong‐Dong Li Delphine Bacq Denise Harold Claudia L. Satizábal Otto Valladares Alessio Squassina Rhodri Thomas Jennifer A. Brody Liming Qu Pascual Sánchez‐Juan Taniesha Morgan Frank J. Wolters Yi Zhao Florentino Sanchez‐García Nicola Denning Myriam Fornage John Malamon María Cándida Déniz Naranjo Elisa Majounie Thomas H. Mosley Beth A. Dombroski David Wallon Michelle K. Lupton Josée Dupuis Patrice L. Whitehead Laura Fratiglioni Christopher Medway Xueqiu Jian Shubhabrata Mukherjee Lina Keller Kristelle Brown Honghuang Lin Laura B. Cantwell Francesco Panza Bernadette McGuinness Sonia Moreno‐Grau Jeremy D. Burgess Vincenzo Solfrizzi Petroula Proitsi Hieab H.H. Adams Mariet Allen Davide Seripa Pau Pástor L. Adrienne Cupples Nathan D. Price Didier Hannequin Ana Frank Daniel Levy Paramita Chakrabarty Paolo Caffarra Ina Giegling Alexa S. Beiser Vilmantas Giedraitis Harald Hampel Melissa E. Garcia Xue Wang Lars Lannfelt Patrizia Mecocci Gudny Eiriksdottir Paul K. Crane Florence Pasquier Virginia Boccardi

10.1038/ng.3916 article EN Nature Genetics 2017-07-17

Our aim was to test the association of vascular risk factor exposure in midlife with progression MRI markers brain aging and measures cognitive decline.A total 1,352 participants without dementia from prospective Framingham Offspring Cohort Study were examined. Multivariable linear logistic regressions implemented study longitudinal change white matter hyperintensity volume (WMHV), (TBV), temporal horn volume, logical memory delayed recall, visual reproductions delayed-recall (VR-d),...

10.1212/wnl.0b013e318227b227 article EN Neurology 2011-08-01

To relate performance on tests of cognitive ability to the subsequent development probable Alzheimer disease (pAD) and identify pattern earliest changes in functioning associated with a diagnosis pAD.From May 1975 November 1979, screening neuropsychological battery was administered Framingham Study participants. They were followed up prospectively for 22 years examined at least every 2 pAD.A community-based center epidemiological research.Subjects 1076 participants aged 65 94 who free...

10.1001/archneur.57.6.808 article EN Archives of Neurology 2000-06-01

The lifetime risk (LTR) of stroke has not been reported for the United States population; such data would assist public education and health planning.Framingham Original cohort participants (n=4897) who were stroke- dementia-free at 55 years age followed biennially up to 51 (115 146 person years). We estimated sex-specific 10-, 20-, 30-year risks LTR developing a by baseline blood pressure (BP) compared it with Alzheimer disease (AD).A total 875 (522 women) developed first-ever stroke; 749...

10.1161/01.str.0000199613.38911.b2 article EN Stroke 2006-01-06

Background: Docosahexaenoic acid (DHA) is an abundant fatty in the brain.In diet, DHA found mostly fish.The content of has been shown to be decreased brain and plasma patients with dementia.Objective: To determine whether phosphatidylcholine (PC) associated risk developing dementia.Design, Setting, Participants: A prospective follow-up study 899 men women who were free dementia at baseline, had a median age 76.0 years, followed up for mean 9.1 years development all-cause Alzheimer...

10.1001/archneur.63.11.1545 article EN Archives of Neurology 2006-11-01

Stroke is emerging as a major public health problem for women, it men. Controversy persists regarding gender differences in stroke incidence, severity, and poststroke disability.Participants the Framingham Original (n=5119; 2829 women) Offspring (n=4957, 2565 cohorts who were 45 years stroke-free followed to first incident stroke. Gender-specific outcome measures adjusted Risk Profile components.We observed 1136 strokes (638 over 56 of follow-up. Women significantly (P<0.001) older (75.1...

10.1161/strokeaha.108.542894 article EN Stroke 2009-02-11

Choline is required to make essential membrane phospholipids. It a precursor for the biosynthesis of neurotransmitter acetylcholine and also an important source labile methyl groups. Mammals fed choline-deficient diet develop liver dysfunction; however, choline not considered nutrient in humans. Healthy male volunteers were hospitalised semisynthetic devoid supplemented with 500 mg/day 1 wk. Subjects randomly divided into two groups, one that continued receive (control), other received no...

10.1096/fasebj.5.7.2010061 article EN The FASEB Journal 1991-04-01
Coming Soon ...